R. Michael Carruthers
2015 - Nivalis Therapeutics
In 2015, R. Michael Carruthers earned a total compensation of $1.7M as Chief Financial Officer at Nivalis Therapeutics.
Compensation breakdown
| Bonus | $70,000 |
|---|---|
| Non-Equity Incentive Plan | $122,198 |
| Option Awards | $1,188,243 |
| Salary | $317,019 |
| Other | $7,950 |
| Total | $1,705,410 |
Carruthers received $1.2M in option awards, accounting for 70% of the total pay in 2015.
Carruthers also received $70K in bonus, $122.2K in non-equity incentive plan, $317K in salary and $8K in other compensation.
Rankings
In 2015, R. Michael Carruthers' compensation ranked 5,390th out of 13,638 executives tracked by ExecPay. In other words, Carruthers earned more than 60.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,390 out of 13,638 | 61st |
Division Manufacturing | 1,998 out of 5,190 | 62nd |
Major group Chemicals And Allied Products | 725 out of 1,854 | 61st |
Industry group Drugs | 576 out of 1,528 | 62nd |
Industry Pharmaceutical Preparations | 453 out of 1,182 | 62nd |
Source: SEC filing on March 21, 2016.
Carruthers' colleagues
We found two more compensation records of executives who worked with R. Michael Carruthers at Nivalis Therapeutics in 2015.